Table 4.
Contingency table summarizing Supplementary Table S2 by contrasting the microarray-derived mode of expression (either M = maternal: uSLR ≥ .6, P = paternal: uSLR ≤ −.6 or B = biallelic) with the mode determined by the UpDp/UpD PCR and/or SNP sequencing assays
| Mode of expression based on microarray measurement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Array-based | Maternal | Paternal | Biallelic | |||||||
| expression mode: | l | M | P | B | M | P | B | M | P | B |
| Tissue | Total | |||||||||
| Pl | 13 | 2 | 2 | 9 | ||||||
| Ampd3 | Dhcr7 | |||||||||
| Tspan4 | Th | |||||||||
| Em | 28 | 9 | 2 | 4 | 13 | |||||
| A330103N21Rik | AK080843 | Ebf3 | ||||||||
| Ccndl | BB264453 | Gabra5 | ||||||||
| Ceacam11-14 | Hbxap | |||||||||
| Cebpa | Rtn4 | |||||||||
| Pank3 | ||||||||||
| Teadl | ||||||||||
| Br | 30 | 1 | 5 | 8 | 11 | 5 | ||||
| Gabral* | Rkhd3 | Inpp5f_v2 | Ebf2 | |||||||
| Rgs10 | AK080843 | Txnl2 | ||||||||
| MGI:2446326 | BM117114 | Mlstd2 | ||||||||
| Arrdc4 | BB312372* | Kcnq5 | ||||||||
| 0710005119Rik | BB264453* | Dlgh2 | ||||||||
| BB182944 | A1114950 | |||||||||
| BB077283 | AA123443 | |||||||||
| AV328498 | 4933439C20Rik | |||||||||
| 4632427E13Rik | ||||||||||
| 4632419K20Rik | ||||||||||
| 2310047115Rik | ||||||||||
| Ht | 2 | 1 | 1 | |||||||
| Sh3gl3 | ||||||||||
For each combination of microarray-derived and assay-derived expression mode, the number of distinct genes that exhibited this combination is provided. Empty entries correspond to zero occurrences. The gene names are given except for genes that showed a biallelic mode of expression in both the microarray and assay experiments. New imprinted genes/transcripts are in bold. *indicates no SNP between Bb and Cast.